Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation

Molecular Immunology

Volumn 46, Issue 8-9, 2009, Pages 1736-1743

  Tonnelle, Cécile ^a,b   Dijon, Marilyne ^a,b   Moreau, Thomas ^a,b   Garulli, Céline ^a,b   Bardin, Florence ^a,b   Chabannon, Christian ^a,b,c,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

Author keywords

B lymphocytes; Human hematopoietic differentiation; Ikaros; Lentiviral vectors; Transcription factors; Xeno transplantation

Indexed keywords

CD19 ANTIGEN; IKAROS TRANSCRIPTION FACTOR; IKAROS TRANSCRIPTION FACTOR 6; IMMUNOGLOBULIN M; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; ENGRAFTMENT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; FEMALE; GENES, DOMINANT; HUMANS; IKAROS TRANSCRIPTION FACTOR; JURKAT CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PREGNANCY; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

MUS;

EID: 64549083639     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.02.004     Document Type: Article

References (59)

1. Cobb B.S., Morales-Alcelay S., Kleiger G., Brown K.E., Fisher A.G., and Smale S.T. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 14 (2000) 2146-2160
2. DeKoter R.P., Lee H.J., and Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16 (2002) 297-309
3. Dijon M., Bardin F., Murati A., Batoz M., Chabannon C., and Tonnelle C. The role of Ikaros in human erythroid differentiation. Blood 111 (2008) 1138-1146
4. Ernst P., Hahm K., and Smale S.T. Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene. Mol. Cell. Biol. 13 (1993) 2982-2992
5. Espeli M., Rossi B., Mancini S.J., Roche P., Gauthier L., and Schiff C. Initiation of pre-B cell receptor signaling: common and distinctive features in human and mouse. Semin. Immunol. 18 (2006) 56-66
6. Galy A., Christopherson I., Ferlazzo G., Liu G., Spits H., and Georgopoulos K. Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. Blood 95 (2000) 128-137
7. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2 (2002) 162-174
8. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., and Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79 (1994) 143-156
9. Georgopoulos K., Moore D.D., and Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258 (1992) 808-812
10. Hahm K., Ernst P., Lo K., Kim G.S., Turck C., and Smale S.T. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol. Cell. Biol. 14 (1994) 7111-7123
11. Haire R.N., Miracle A.L., Rast J.P., and Litman G.W. Members of the Ikaros gene family are present in early representative vertebrates. J. Immunol. 165 (2000) 306-312
12. Hardy R.R., Kincade P.W., and Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity 26 (2007) 703-714
13. Harker N., Naito T., Cortes M., Hostert A., Hirschberg S., Tolaini M., Roderick K., Georgopoulos K., and Kioussis D. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol. Cell 10 (2002) 1403-1415
14. Hiramatsu H., Nishikomori R., Heike T., Ito M., Kobayashi K., Katamura K., and Nakahata T. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood 102 (2003) 873-880
15. Holmes M.L., Pridans C., and Nutt S.L. The regulation of the B-cell gene expression programme by Pax5. Immunol. Cell. Biol. 86 (2008) 47-53
16. Iacobucci I., Lonetti A., Messa F., Cilloni D., Arruga F., Ottaviani E., Paolini S., Papayannidis C., Piccaluga P.P., Giannoulia P., Soverini S., Amabile M., Poerio A., Saglio G., Pane F., Berton G., Baruzzi A., Vitale A., Chiaretti S., Perini G., Foa R., Baccarani M., and Martinelli G. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 112 (2008) 3847-3855
17. Kelley C.M., Ikeda T., Koipally J., Avitahl N., Wu L., Georgopoulos K., and Morgan B.A. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8 (1998) 508-515
18. Kirstetter P., Thomas M., Dierich A., Kastner P., and Chan S. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32 (2002) 720-730
19. Koipally J., and Georgopoulos K. Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression. J. Biol. Chem. 277 (2002) 23143-23149
20. Kozmik Z., Wang S., Dorfler P., Adams B., and Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12 (1992) 2662-2672
21. Logan A.C., Lutzko C., and Kohn D.B. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 13 (2002) 429-436
22. Ma S., Pathak S., Trinh L., and Lu R. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111 (2008) 1396-1403
23. Meffre E., Casellas R., and Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 1 (2000) 379-385
24. Molnar A., and Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14 (1994) 8292-8303
25. Molnar A., Wu P., Largespada D.A., Vortkamp A., Scherer S., Copeland N.G., Jenkins N.A., Bruns G., and Georgopoulos K. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J. Immunol. 156 (1996) 585-592
26. Moreau T., Bardin F., Imbert J., Chabannon C., and Tonnelle C. Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. Mol. Ther. 10 (2004) 45-56
27. Moreau T., Barlogis V., Bardin F., Nunes J.A., Calmels B., Chabannon C., and Tonnelle C. Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. Gene Ther. 15 (2008) 942-952
28. Morgan B., Sun L., Avitahl N., Andrikopoulos K., Ikeda T., Gonzales E., Wu P., Neben S., and Georgopoulos K. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16 (1997) 2004-2013
29. Movassagh M., Laderach D., and Galy A. Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Th1 T cell differentiation. Int. Immunol. 16 (2004) 867-875
30. Mullighan C.G., Miller C.B., Radtke I., Phillips L.A., Dalton J., Ma J., White D., Hughes T.P., Le Beau M.M., Pui C.H., Relling M.V., Shurtleff S.A., and Downing J.R. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453 (2008) 110-114
31. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., Ma J., Liu W., Cheng C., Schulman B.A., Harvey R.C., Chen I.M., Clifford R.J., Carroll W.L., Reaman G., Bowman W.P., Devidas M., Gerhard D.S., Yang W., Relling M.V., Shurtleff S.A., Campana D., Borowitz M.J., Pui C.H., Smith M., Hunger S.P., Willman C.L., and Downing J.R. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360 (2009) 470-480
32. Naito T., Gomez-Del Arco P., Williams C.J., and Georgopoulos K. Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression. Immunity 27 (2007) 723-734
33. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
34. Ng S.Y., Yoshida T., Georgopoulos K., Yoshida T., Ng S.Y., Zuniga-Pflucker J.C., and Georgopoulos K. Ikaros and chromatin regulation in early haematopoiesis. Early hematopoietic lineage restrictions directed by Ikaros. Curr. Opin. Immunol. 19 (2007) 116-122
35. Nichogiannopoulou A., Trevisan M., Neben S., Friedrich C., and Georgopoulos K. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190 (1999) 1201-1214
36. Nietfeld W., and Meyerhans A. Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of mouse Ikaros/LyF-1. Immunol. Lett. 49 (1996) 139-141
37. Nishii K., Katayama N., and Shiku H. Adult acute myeloid leukemia cells do not express nonfunctional Ikaros isoforms. Blood 100 (2002) 3436-3437
38. Nutt S.L., and Kee B.L. The transcriptional regulation of B cell lineage commitment. Immunity 26 (2007) 715-725
39. Papathanasiou P., Perkins A.C., Cobb B.S., Ferrini R., Sridharan R., Hoyne G.F., Nelms K.A., Smale S.T., and Goodnow C.C. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19 (2003) 131-144
40. Pridans C., Holmes M.L., Polli M., Wettenhall J.M., Dakic A., Corcoran L.M., Smyth G.K., and Nutt S.L. Identification of Pax5 target genes in early B cell differentiation. J. Immunol. 180 (2008) 1719-1728
41. Reynaud D., Demarco I.A., Reddy K.L., Schjerven H., Bertolino E., Chen Z., Smale S.T., Winandy S., and Singh H. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9 (2008) 927-936
42. Sabbattini P., Lundgren M., Georgiou A., Chow C., Warnes G., and Dillon N. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20 (2001) 2812-2822
43. Schiff C., Milili M., and Fougereau M. Isolation of early immunoglobulin lambda-like gene transcripts in human fetal liver. Eur. J. Immunol. 19 (1989) 1873-1878
44. Sirven A., Ravet E., Charneau P., Zennou V., Coulombel L., Guetard D., Pflumio F., and Dubart-Kupperschmitt A. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther. 3 (2001) 438-448
45. Sun L., Heerema N., Crotty L., Wu X., Navara C., Vassilev A., Sensel M., Reaman G.H., and Uckun F.M. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukaemia. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 680-685
46. Sun L., Liu A., and Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15 (1996) 5358-5369
47. Tanaka T., Tsudo M., Karasuyama H., Kitamura F., Kono T., Hatakeyama M., Taniguchi T., and Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 147 (1991) 2222-2228
48. Thomas R.M., Chunder N., Chen C., Umetsu S.E., Winandy S., and Wells A.D. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J. Immunol. 179 (2007) 7305-7315
49. Thompson E.C., Cobb B.S., Sabbattini P., Meixlsperger S., Parelho V., Liberg D., Taylor B., Dillon N., Georgopoulos K., Jumaa H., Smale S.T., Fisher A.G., and Merkenschlager M. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26 (2007) 335-344
50. Tian J., Okabe T., Miyazaki T., Takeshita S., and Kudo A. Pax-5 is identical to EBB-1/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes. Eur. J. Immunol. 27 (1997) 750-755
51. Tonnelle C., Bardin F., Maroc C., Imbert A.M., Campa F., Dalloul A., Schmitt C., and Chabannon C. Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage. Blood 98 (2001) 2673-2680
52. Tonnelle C., Calmels B., Maroc C., Gabert J., and Chabannon C. Ikaros gene expression and leukemia. Leuk. Lymphoma 43 (2002) 29-35
53. Tonnelle C., Imbert M.C., Sainty D., Granjeaud S., N'Guyen C., and Chabannon C. Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen. Hematol. J. 4 (2003) 104-109
54. Trinh L.A., Ferrini R., Cobb B.S., Weinmann A.S., Hahm K., Ernst P., Garraway I.P., Merkenschlager M., and Smale S.T. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15 (2001) 1817-1832
55. Uchida N., Sutton R.E., Friera A.M., He D., Reitsma M.J., Chang W.C., Veres G., Scollay R., and Weissman I.L. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11939-11944
56. Wang J.H., Avitahl N., Cariappa A., Friedrich C., Ikeda T., Renold A., Andrikopoulos K., Liang L., Pillai S., Morgan B.A., and Georgopoulos K. Aiolos regulates B cell activation and maturation to effector state. Immunity 9 (1998) 543-553
57. Wang J.H., Nichogiannopoulou A., Wu L., Sun L., Sharpe A.H., Bigby M., and Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5 (1996) 537-549
58. Winandy S., Wu P., and Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83 (1995) 289-299
59. Zufferey R., Donello J.E., Trono D., and Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73 (1999) 2886-2892